South and Central America Extracellular Matrix Market Growth Drivers and Forecast by 2027

The South and Central America extracellular matrix market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1%  from 2020 to 2027.

The growth of the market is attributed to the increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as , insufficient preservation of vasculature and extracellular matrix composition hinders the growth of the market.

The significantly rising incidences of the orthopaedic trauma conditions and cardiovascular diseases among others are the leading factors for the South and Central America Extracellular Matrix market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantages of the extracellular matrix serve the demand of the patients.

Additionally, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector‐borne diseases and community‐acquired infections and high rates of non‐communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).

South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (US$ Thousand)

South and Central America Extracellular Matrix Market Segmentation

By Application

• Vascular Repair and Reconstruction
• Dural Repair
• Wound Healing
• Cardiac Repair
• Pericardial Repair
• Soft Tissue Repair

By Raw Material

• Bovine
• Porcine
• Other Raw Material

Company Profiles          

• Organogenesis Inc.
• Integra Life Sciences Corporation
• Mölnlycke Health Care AB
• Anika Therapeutics, Inc.
• ACell Inc.
• MIROMATRIX MEDICAL Inc
• Acera Surgical Inc., CorMatrix, Inc.
• Hollister Incorporated
• MLM Biologics Inc.
• Harbor MedTech, Inc.

South and Central America Extracellular Matrix Report Scope